In recurrent ovarian cancer, secondary surgery does not extend survivalNovember 18, 2019Gynecologic Cancer
Molecule exhibits activity in heavily pretreated, HER2-positive solid tumorsNovember 11, 2019Breast CancerGynecologic CancerGastroenterologyImmunotherapyImmuno-oncologyGastrointestinal Cancer
USPSTF recommendations on risk assessment, genetic counseling, and genetic testing for BRCA-related cancerOctober 28, 2019Preventive CareBreast CancerGynecologic Cancer
Veliparib improves PFS in high-grade serous epithelial ovarian cancerOctober 17, 2019Gynecologic Cancer
Pilot program benefits gynecologic cancer patients with malignant bowel obstructionOctober 10, 2019Gynecologic CancerPractice Management
PAOLA-1/ENGOT-ov25 trial: PARP inhibitor for maintenance improves PFS in advanced ovarian cancerSeptember 29, 2019Gynecologic Cancer
BAROCCO study: Cediranib-olaparib combination shows promise in PROCSeptember 28, 2019Gynecologic Cancer
Closure of women’s health clinics may negatively impact cervical cancer outcomesSeptember 22, 2019Preventive CareGynecologic Cancer
FDA approves pembrolizumab/lenvatinib combo for advanced endometrial carcinomaSeptember 17, 2019Gynecologic Cancer
Nivolumab may be beneficial for recurrent or metastatic cervical cancerSeptember 14, 2019Gynecologic Cancer
